Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where M. Santos is active.

Publication


Featured researches published by M. Santos.


International Journal of Radiation Oncology Biology Physics | 2014

Prospective Coronary Heart Disease Screening in Asymptomatic Hodgkin Lymphoma Patients Using Coronary Computed Tomography Angiography: Results and Risk Factor Analysis

T. Girinsky; Radhia M’kacher; Nathalie Lessard; Serge Koscielny; Eric Elfassy; François Raoux; Patrice Carde; M. Santos; Jean-Pierre Margainaud; Laure Sabatier; Mithra Ghalibafian; Jean-François Paul

PURPOSE To prospectively investigate the coronary artery status using coronary CT angiography (CCTA) in patients with Hodgkin lymphoma treated with combined modalities and mediastinal irradiation. METHODS AND MATERIALS All consecutive asymptomatic patients with Hodgkin lymphoma entered the study during follow-up, from August 2007 to May 2012. Coronary CT angiography was performed, and risk factors were recorded along with leukocyte telomere length (LTL) measurements. RESULTS One hundred seventy-nine patients entered the 5-year study. The median follow-up was 11.6 years (range, 2.1-40.2 years), and the median interval between treatment and the CCTA was 9.5 years (range, 0.5-40 years). Coronary artery abnormalities were demonstrated in 46 patients (26%). Coronary CT angiography abnormalities were detected in nearly 15% of the patients within the first 5 years after treatment. A significant increase (34%) occurred 10 years after treatment (P=.05). Stenoses were mostly nonostial. Severe stenoses were observed in 12 (6.7%) of the patients, entailing surgery with either angioplasty with stent placement or bypass grafting in 10 of them (5.5%). A multivariate analysis demonstrated that age at treatment, hypertension, and hypercholesterolemia, as well as radiation dose to the coronary artery origins, were prognostic factors. In the group of patients with LTL measurements, hypertension and LTL were the only independent risk factors. CONCLUSIONS The findings suggest that CCTA can identify asymptomatic individuals at risk of acute coronary artery disease who might require either preventive or curative measures. Conventional risk factors and the radiation dose to coronary artery origins were independent prognostic factors. The prognostic value of LTL needs further investigation.


American Journal of Clinical Oncology | 1990

Intraoperative and external beam radiotherapy in invasive bladder cancer: pathological findings following cystectomy.

Felipe A. Calvo; Ivan Henriquez; M. Santos; Oscar Abuchaibe; D. Ortiz de Urbina; J. Pardo; S. Valerdiz; J. Zudaire; J.M. Berian

The pathological findings observed following intraoperative radiotherapy (IORT) boost (15Gy) to the whole bladder, external beam fractionated irradiation (46Gy in 5 weeks), and planned radical cystectomy in patients with deep invasive bladder carcinoma are analyzed. Clinical pretreatment stage of disease was T3 (16 cases) and T4 (two cases). No evidence of residual tumor (pT0) was demonstrated in 11 cystectomy specimens (61%) and residual tumor (pT1) was observed in seven (39%). Toxicity and complications related to the treatment approaches were minor and reversible. It is concluded that IORT is a feasible boosting modality in the management of invasive bladder cancer, able to induce high rates of pT0 cystectomy specimens, and might be considered as a valuable technique for organ preservation treatment programs.


Archive | 1999

IORT for CNS Tumors

D. Ortiz de Urbina; Normann Willich; R. R. Dobelbower; Javier Aristu; J.C. Bustos; D. Carter; S. Palkovic; M. Santos; Felipe A. Calvo

High-grade malignant gliomas are the most common brain tumors of the adult life and account for about 30–45% of the primary human brain tumors. Of these, nearly 85% are glioblastoma multiforme (1).


Neurocirugia | 1994

El control de calidad en los tratamientos de radiocirugía. Recomendaciones metodológicas

José Samblás; J.C. Bustos; José A. Gutiérrez-Díaz; G. Donckaster; M. Santos; D. Ortiz de Urbina; M. Pérez-Romero

Resumen La radiocirugia estereotaxica es una tecnica neuroquirurgica utilizada para el tratamiento de malformaciones arteriovenosas y de algunos tumores cerebrales. Se basa en la administracion de una dosis de radiacion, con gran exactitud y muy concentrada, en el volumen patologico. Utiliza diversos equipamientos: un sistema esterotaxico de localizacion espacial, equipos de identificacion de la lesion -TAC, RM o angiografia-; un sistema computarizado de planificacion y dosimetria, un sistema de posicionamiento del paciente y el sistema de irradiacion. Las caracteristicas del procedimiento de radiocirugia, donde el cumplimiento de una metodologia es basico, hacen conveniente la utilizacion de un protocolo de tratamiento, que a la vez sirva de control de calidad. El protocolo que se presenta ha sido utilizado en 300 casos tratados en la Unidad de Radiocirugia del Sanatorio San Francisco de Asis de Madrid. Esta dividido en 8 fases: recopilacion de datos e identificacion; colocacion de la guia estereotaxica, realizacion de TAC cerebral, angiografia cerebral (en malformaciones arteriovenosas), procesamiento e integracion de imagenes, planificacion y dosimetria, instalacion del equipamiento de radiocirugia en el acelerador lineal y tratamiento. Se destaca la necesidad de actuacion coordinada de los distintos especialistas –neurocirujanos, radioterapeutas, radiofisicos, neuroradiologos, informaticos, tecnicos operadores y de mantenimiento, ATS especializados, etc.– y de la disponibilidad de los equipos de diagnostico, planificacion y tratamiento.


Frontiers of Radiation Therapy and Oncology | 1997

Intense Local Therapy in Primary Rectal Cancer: Multi-Institutional Results with Preoperative Chemo-Radiation Therapy Plus IORT

Ignacio Azinovic; Felipe A. Calvo; M. Santos; Javier Aristu; R. Martínez-Monge; D. Ortíz de Urbina


Neurocirugia | 1999

Tratamiento con radiocirugía estereotáxica del glioma cerebral primario de alto grado

D. Ortiz de Urbina; M. Santos; José Samblás; J. M. Delgado; J.C. Bustos; José A. Gutiérrez-Díaz; I. García-Berrocal; Salvador Rodríguez; M. Rubio; G. Donckaster; F. Sansivirini; Felipe A. Calvo


Clinical & Translational Oncology | 2013

Intra-operative electron beam radiotherapy for newly diagnosed and recurrent malignant gliomas: feasibility and long-term outcomes

Sergey Usychkin; Felipe A. Calvo; M. Santos; José Samblás; David Ortiz de Urbina; J.C. Bustos; José Díaz; Kita Sallabanda; Ana Sanz; Carmen Yélamos; Carmen Peraza; J. M. Delgado; H. Marsiglia


Frontiers of Radiation Therapy and Oncology | 1997

IORT in Primary Rectal Cancer (T3-4Nx): Multi-Institutional Experience with Conventional Treatment Sequence

Ignacio Azinovic; Felipe A. Calvo; M. Santos; Javier Aristu; R. Martínez-Monge; D. Ortíz de Urbina


Value in Health | 2012

PMD50 Cost-Effectiveness Analysis of Four Validated Techniques of Accelerated Partial Breast Irradiation for the Treatment of Early-Stage Breast Cancer: Spanish Public Health System Standard Estimations

M. Santos; J.L.L. Guerra; M.J.O. Gordillo; A. Fondevilla; F. Calvo; J. Samblás; H. Marsiglia


Archive | 2011

Stereotactic radiosurgery as a salvage treatment option for atypical meningiomas previously submitted to surgical resection

Kita Sallabanda; Marcos Antonio dos Santos; José Bustos Pérez de Salcedo; José Díaz; Felipe A. Calvo; José Samblás; H. Marsiglia; M. Santos

Collaboration


Dive into the M. Santos's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

H. Marsiglia

Institut Gustave Roussy

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge